HUB's blog

The KRAS Conundrum: Challenges and strategies for targeted therapies in cancer

The KRAS Conundrum: Challenges and strategies for targeted therapies in cancer

Published by Dnyanada Sahasrabudhe on Jul 23, 2024

KRAS is a proto-oncogene that is crucial in regulating cell growth and division. Mutations in the KRAS gene are commonly found in various cancers, including colorectal pancreatic, and lung cancers. These mutations can lead to the constitutive activation of the RAS signaling pathway, promoting ...

read more

Ask the Expert: How can patient-derived organoids accelerate KRAS drug development?

Ask the Expert: How can patient-derived organoids accelerate KRAS drug development?

Published by HUB Organoids on Jul 5, 2024

In this edition of Ask the Expert, featuring Dr. Yasmine Abouleila, ...

read more

Ask the experts: Revolutionizing Oncology Drug Development with Organoid Technology

Ask the experts: Revolutionizing Oncology Drug Development with Organoid Technology

Published by HUB Organoids on May 7, 2024

This "Ask the Experts" feature delves into the pressing inquiries ...

read more

A beginner’s guide to Inflammatory Bowel Diseases (IBD)

A beginner’s guide to Inflammatory Bowel Diseases (IBD)

Published by HUB Organoids on Feb 26, 2024

Inflammatory Bowel Disease (IBD) is a complex condition that affects ...

read more

Decoding adult stem cells: exploring the hallmarks of stemness

Decoding adult stem cells: exploring the hallmarks of stemness

Published by HUB Organoids on Feb 19, 2024

Discover the 6 hallmarks of stemness in adult tissue Mammalian organ ...

read more

Ask the Experts – organoid & immune cell co-cultures for immunotherapy

Ask the Experts – organoid & immune cell co-cultures for immunotherapy

Published by HUB Organoids on Jun 23, 2023

In this post of our "Ask the Experts" series, we provide ...

read more

PDO Screen – Patient-derived Organoids meet Cancer Modeling

PDO Screen – Patient-derived Organoids meet Cancer Modeling

Published by HUB Organoids on Mar 21, 2023

Discover how patient-derived organoids can revolutionize oncology ...

read more

The FDA Modernization Act 2.0: A patient-centric paradigm shift in drug development

The FDA Modernization Act 2.0: A patient-centric paradigm shift in drug development

Published by HUB Organoids on Jan 16, 2023

Explore what the new legislative bill means for the future of ...

read more

Challenges in preclinical modeling of cancer immunity

Challenges in preclinical modeling of cancer immunity

Published by HUB Organoids on Nov 1, 2022

Learn how to select the right model for your immunotherapy ...

read more

Do you need a license to work with HUB Organoid® Technology?

Do you need a license to work with HUB Organoid® Technology?

Published by Dnyanada Sahasrabudhe on Jul 7, 2022

Explore HUB’s license offerings and how they apply to your organoid ...

read more